Login to Your Account


HONG KONG – Travecta Therapeutics Pte Ltd. is the latest startup to join Singapore's biotech block. The newly formed drug discovery company is based on intellectual property derived from discoveries made at Duke-NUS Medical School (Duke-NUS).

SHANGHAI - XW Laboratories Inc.'s lead candidate, a small-molecule drug for narcolepsy, has begun dosing in healthy patients in Australia. Based in Wuhan and Taipei, XW Labs decided to head to Australia for phase I for a variety of reasons, even though moving to first-in-human trials in China has become more viable after CFDA reforms.

HONG KONG –With a new deal with Ferring Holdings Ltd. to option its innovative microbiome-focused technology, Israel's Mybiotics Pharma Ltd. is looking to expand its market and develop new products. Its second option agreement with Ferring is based on validation of Mybiotics' microbiome-based therapeutic technology focused on women's health.

More Newco News Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: